Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+ Breast Cancer × elacestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Sarcoma, Endometrial Stromal 1 Recurrence 1 Perivascular Epithelioid Cell Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Endometrial Neoplasms 1 ESR1 Gene Mutation 1 ER+ Breast Cancer 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Cancer Patients 1 Brain Neoplasms 1 Brain Diseases 1 Advanced ER+, HER2-Negative Breast Cancer 1 Advanced Breast Cancer 1 Adenosarcoma of the uterus 1

Interventions

Tamoxifen 2 palbociclib 1 exemestane 1 elacestrant 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06923527 2026-03-16

Circulating Tumor DNA

Yale University

Phase 2 Recruiting

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡